Cargando…
Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study
BACKGROUND: To evaluate 5-year outcomes of anti-vascular endothelial growth factor (VEGF) monotherapy and combination therapy of anti-VEGF agents and photodynamic therapy (PDT) for polypoidal choroidal vasculopathy (PCV) in a real-world Chinese population. METHODS: Retrospective study. Fifty-three e...
Autores principales: | Yang, Jingyuan, Yuan, Mingzhen, Wang, Erqian, Xia, Song, Chen, Youxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873695/ https://www.ncbi.nlm.nih.gov/pubmed/31752769 http://dx.doi.org/10.1186/s12886-019-1245-4 |
Ejemplares similares
-
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
por: Yang, Jingyuan, et al.
Publicado: (2019) -
Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
por: Yang, Jingyuan, et al.
Publicado: (2019) -
Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013) -
The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers
por: Luo, Mingyue, et al.
Publicado: (2020) -
Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2014)